Literature DB >> 3873249

Matrix protein profiles in calf bone development.

K M Conn, J D Termine.   

Abstract

The major noncollagenous proteins (NCP) of the mineralized extracellular matrix of bovine bone were present from early fetal life through adulthood. The alpha 2-HS-glycoprotein was the dominant bone NCP at 2 months in utero and then diminished with advancing fetal age. Osteocalcin levels were quite low in early fetal bone, became elevated near term, reached a maximum shortly after birth, and dropped again in adult bone. Osteonectin levels were relatively constant at all stages of bone development, but somewhat lower values were seen in woven bone than in lamellar bone matrix. For a given fetus, NCP profiles were identical in both flat and long bones. The 24,000 dalton phosphoprotein was significantly elevated in fetal secondary spongiosa, bony areas known to be undergoing extensive resorption. Adult bone matrix contained greater quantities of lower and intermediate molecular weight NCPs compared to actively forming fetal bone.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3873249     DOI: 10.1016/8756-3282(85)90404-1

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  5 in total

1.  Immunohistochemical localization of osteonectin in developing human and calf bone using monoclonal antibodies.

Authors:  P Bianco; G Silvestrini; J D Termine; E Bonucci
Journal:  Calcif Tissue Int       Date:  1988-09       Impact factor: 4.333

2.  Age- and gender-related changes in the distribution of osteocalcin in the extracellular matrix of normal male and female bone. Possible involvement of osteocalcin in bone remodeling.

Authors:  R T Ingram; Y K Park; B L Clarke; L A Fitzpatrick
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

3.  Osteonectin content in human osteogenesis imperfecta bone shows a range similar to that of two bovine models of OI.

Authors:  L W Fisher; M A Drum; P G Robey; K M Conn; J D Termine
Journal:  Calcif Tissue Int       Date:  1987-05       Impact factor: 4.333

4.  Fetuin, matrix-Gla protein and osteopontin in calcification of renal allografts.

Authors:  Johan M Lorenzen; Filippo Martino; Irina Scheffner; Verena Bröcker; Holger Leitolf; Hermann Haller; Wilfried Gwinner
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

5.  Fetuin-A and fetal growth in gestational diabetes mellitus.

Authors:  Wen-Juan Wang; Lin Zhang; Tao Zheng; Guang-Hui Zhang; Kun Du; Meng-Nan Yang; Hua He; Shufan Wang; Weiye Wang; Jun Zhang; Fengxiu Ouyang; Zhong-Cheng Luo
Journal:  BMJ Open Diabetes Res Care       Date:  2020-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.